Vegan or Animal Protein Ingestion on the Recovery of Muscle Function Following Exercise

NCT ID: NCT04156386

Last Updated: 2023-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-23

Study Completion Date

2022-04-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will assess the effect of daily post-exercise vegan (pea) and animal (whey) protein ingestion compared to placebo over 7 days of recovery from strenuous exercise. Muscle strength and soreness will be measured daily, and mechanisms underpinning recovery will be investigated in muscle biopsies taken 3, 24 and 48 hours after exercise.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Strenuous exercise can cause muscle soreness and reduced muscle strength. It is widely acknowledged that nutritional supplements derived from animal protein sources, including whey from milk, aids recovery when taken immediately after strenuous exercise. However, the effect of vegan protein supplements are less understood, and how they affect recovery of strength and soreness is not known. This is an important area of research due to the increasing demand for plant-based protein.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscle Recovery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Animal Protein

Group Type ACTIVE_COMPARATOR

Recovery animal (20g whey) protein supplement

Intervention Type DIETARY_SUPPLEMENT

Animal protein supplement consumed post exercise to aid recovery of muscle function following strenuous exercise.

Vegan Protein

Group Type ACTIVE_COMPARATOR

Recover vegan (26g pea) protein supplement

Intervention Type DIETARY_SUPPLEMENT

Vegan protein supplement consumed post exercise to aid recovery of muscle function following strenuous exercise.

Placebo

Group Type PLACEBO_COMPARATOR

Placebo (32g maltodextrin)

Intervention Type DIETARY_SUPPLEMENT

Placebo consumed post exercise to aid recovery of muscle function following strenuous exercise.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Recovery animal (20g whey) protein supplement

Animal protein supplement consumed post exercise to aid recovery of muscle function following strenuous exercise.

Intervention Type DIETARY_SUPPLEMENT

Recover vegan (26g pea) protein supplement

Vegan protein supplement consumed post exercise to aid recovery of muscle function following strenuous exercise.

Intervention Type DIETARY_SUPPLEMENT

Placebo (32g maltodextrin)

Placebo consumed post exercise to aid recovery of muscle function following strenuous exercise.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Recreationally active
* 18-40 years of age

Exclusion Criteria

* Regular and structured involvement in resistance training
* Inactive participants
* Habitual dietary protein intake \<0.8g/kg bw/day and \>2.0g/kg bw/day
* Use of nutritional supplements
* Any diagnosed metabolic conditions (diabetes), cardiovascular disease or hypertension
* Current musculoskeletal injury
* Use of anti-inflammatory medicines
* Individuals with non -removable metallic implants (including heart pacemaker, cochlea implants, medication pumps, surgical clips, plates or screws) or claustrophobia
* Individuals with an allergy to egg, fish, wheat or soy ingredients as the product is manufactured in a facility that contains these ingredients
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beachbody

INDUSTRY

Sponsor Role collaborator

University of Exeter

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francis Stephens

Role: PRINCIPAL_INVESTIGATOR

University of Exeter

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Exeter

Exeter, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

190703-B-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.